Drug recall · December 25, 2013
Bethel Advance recall
Why: Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Bethel Advance (bitter orange, mulberry leaf, cassia seed extract, jobstear seed, spirulina, starch, kola nut) capsules, 400 mg, 30-count bottles, Distributed by: Bethel, Inc., Tel: (212) 568-5330, UPC 1 60126 41750 9.
- Lots / codes
Lot 10092011, Exp 2014
- Quantity
- 13,266 bottles
- Company
- Bethel Nutritional Consulting, Inc, New York, NY
- Distribution
- Nationwide, Puerto Rico, and internet sales
- Initiated
- August 5, 2013 · Voluntary: Firm initiated
- Classified
- December 18, 2013
- Reported
- December 25, 2013
- Ended
- May 30, 2018
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.